Summary
Overview
Work History
Education
Skills
Mobile Numbers
Corresponding Address
Research Collaborations
Patents
Grant Research Proposals Submitted
Publications
References
Personal data processing
Timeline
Generic
Nikunj Solanki

Nikunj Solanki

Professor

Summary

Dynamic professor and founder at the forefront of innovation in pharmaceutical biotechnology and AI, specializing in CRISPR-Cas/LAMP biosensors, diagnostic kit and therapeutics development, pharmacokinetics (PK/PD), nanotechnology, animal tissue culture, microbiology, and in-silico modeling (molecular docking and dynamics). Proven ability to guide over 10 postgraduate researchers while leading multi-institutional collaborations with esteemed organizations such as ICMR-NIV, Symbiosis, and MIT-ADT. Seasoned academic administrator with a strong track record in conducting hands-on AI workshops and national events, successfully translating laboratory research into commercially viable products. Currently engaged in building three startups aimed at delivering cost-effective point-of-care diagnostics and therapeutics.

Overview

2026
2026
years of professional experience
4
4
Languages

Work History

Startup Founder

Shakite Wellness
2025 - Current

Shaktie Wellness is a startup led by me and Dr. Sonal Solanki, with students contributing to R&D and execution. We develop evidence-based nutraceuticals and herbal sprays that blend traditional wisdom with modern pharmaceutical science. Our pipeline is backed by applied patents, accelerating productization, and commercialization.

https://shaktiewellness.com/

Startup Founder

EdCredo
2025 - Current

EdCredo is an education-led venture, that delivers hands-on programs to help students and faculty write research papers, patents, and books, with real outcomes. We are currently developing VR/AR lab simulations (ePrayogshala) for skill development.

www.edcredo.com

Startup Founder

LYL India
2025 - Current

Lyl India is a CRISPR- and LAMP-technology startup cofounded with Dr. Sonal Solanki and a network of reputed scientists. We develop biosensors and diagnostic kits for the One Health ecosystem, purpose-built for low-resource settings , and are also advancing CRISPR-based therapeutics .

www.lylindia.com .

Prof

Hon. Shri Babanrao Pachpute Vichardhara Trust's Group of Institutions
04.2024 - Current
  • Lecture
  • NAAC, QCI Coordinator
  • Industry Innovation council Coordinator
  • Startup coordinator
  • Conferences, FDP, online workshops Convener



Marketing CEO

SAI Pharma
11.2015 - 12.2021
  • Built productive relationships with industry partners and competitors to support strategic business objectives.

Asst. Prof

Vidyabharti Trust College of Pharmacy
09.2006 - 07.2015
  • Lecturer
  • I/C Principal
  • Academic In-charge
  • Exam coordinator

Education

Ph.D. - Pharmaceutical Sciences

Hemchandracharya North Gujarat University
Patan, Gujarat
01.2023

M. Pharm. - Pharmaceutical Biotechnology

Bharti vidyapeeth's Poona College of Pharmacy
01.2006

High School Diploma - GATE - Conducted By Indian Institute of Technology

GATE
Conducted By Indian Institute Of Technology (IIT),
04.2001 -

B. Pharm. -

ROFEL College of Pharmacy
Vapi, Gujarat
01.2003

Skills

Academic Research and publication

Grant writing

Networking and Collaboration

Multitasking

Problem-solving abilities

Decision-making

Entrepreneurial and innovative

Mobile Numbers

  • +918928035979
  • +919016454096

Corresponding Address

404, Parikrama Staff quarters, Parikrama Campus, Kashti, 414701.

Research Collaborations

Collaborated with pharmacy, biotech, medical, veterinary, and AI/computing domains , demonstrating strong interdisciplinary linkages.

Patents

  • One-Pot Device for Rapid RNA Isolation from Biological Fluids
    Patent Application No: 202521067168 A | Filing Date: 15/07/2025 | Publication Date: 01/08/2025
  • Circular Lateral Flow Assay Device with Central Sample Distribution Hub for Multiplex Biomarker Detection
    Patent Application No: 202521093630 | Form 1 filed, Sept 2025
  • Herbal Vaginal Spray Formulation for Prevention and Relief of Urinary Tract Infections (UTIs)
    Patent Application No: 20252109183 | Form 1 filed, Sept 2025
  • Brain-Targeted Dry Powder Nanoparticulate Nasal Formulation
    Patent No: IN 202121031197 | Filing Date: 27/07/2020 | Published: 27/08/2021
  • Inhaler Device for Brain-Targeted Drug Delivery
    Patent No: IN 202121031195 | Filing Date: 12/07/2021 | Published: 14/01/2023
  • Circular Lateral Flow Assay Device
    Design Patent | Under submission
  • AI-Enameled UV-Visible Spectrophotometer
    Design Patent | Under submission
  • Chitosan-Coated Swab for Direct Capture of Nucleic Acids for Molecular Diagnostics
    Provisional Patent | Under submission
  • Herbal Lung Spray Formulation for Prevention and Mitigation of Pollution-Induced Respiratory Damage
    Utility Patent | Under submission


Grant Research Proposals Submitted

  • Development of a New Colorimetric MUHIT-LAMP™ Assay-Based Biosensor for Rapid and On-Site Detection of Lumpy Skin Disease Virus (LSDV)
    Investigators: Nikunj Solanki, Sonal Solanki, Shyam Sundar Nandi
    Role: Principal Investigator
    Submitted to: ANRF – IRG (Inclusivity Research Grant) Scheme
    Ref. No.: 512025000711 | Date: 15 July 2025
    Proposed Budget: ₹71,80,800
  • Development of a Field-Deployable, User-Friendly CRISPR–Cas13a-Based mRNA Detection Kit for Early Diagnosis of Bovine Viral Diarrhea Virus (BVDV) in Cattle
    Investigators: Sonal Solanki, Shama Aphale, Nikunj Solanki, Deepali Bansode, Shyam Sundar Nandi
    Role: Co-Investigator
    Submitted to: ANRF – ARG (Advanced Research Grant) Scheme
    File No.: ANRF/ARG/2025/010922 | Date: 15 July 2025
    Proposed Budget: ₹4,34,30,305
  • Point-of-Care Detection of Tuberculosis from Saliva and Blood Using a Rapid, Low-Cost CRISPR–Cas13a Assay
    Investigators: Nikunj Solanki, Sonal Solanki, Ruchika Kaul-Ghanekar, Atul Kulkarni, Sunil Saroj, Ashwini Kamble
    Role: Co-Investigator
    Submitted to: BIRAC – GIC-TB Call
    Proposal Ref. No.: BT/TEMP26140/GCI-ETBD-15/25
    Proposed Budget: ₹50 Lakhs
  • Centre for Advanced Research on Circulating miRNA Signatures in Diabetes: AI-Enabled Risk Prediction of Complications
    Investigators: Abhay Harsulkar, Nikunj Solanki, Sonal Solanki, Jayashree Prasad
    Role: Co-Investigator
    Submitted to: ICMR – CAR (Centre for Advanced Research)
    Proposal ID: CAR-2025-01-000809
    Funding: Multi-crore, Centre-level support expected
  • National Image Informatics Biobank for Buffalopox: Integrated High-Frequency Imaging, Laboratory Validation and Data Hub
    Investigators: Nikunj Solanki, Shyam Sundar Nandi, Abhay Harsulkar
    Role: Co-Investigator
    Submitted to: DBT – COE (Image Data Bank Initiative)

Publications

Published Communicated / Under Communication Book Chapters — Communicated / Under Communication PROSPERO Registered Systematic Reviews

  • Development, Optimization, and Characterization of Nanoengineered Drug Delivery Platforms for Tamoxifen: A Next-Generation Strategy for Sustained and Targeted Release in Hormone-Responsive Breast Cancer Treatment
    Journal of Carcinogenesis | 2025 | Journal article | DOI: 10.64149/j.carcinog.24.2s.83-96
  • Formulation, Characterization, and In Vitro Cytotoxic Evaluation of Etoposide-Loaded Nanobubbles for Enhanced Cancer Chemotherapy
    Journal of Carcinogenesis | 2025 | Journal article | DOI: 10.64149/j.carcinog.24.2s.666-677
  • Formulation and Characterization of Lovastatin Tablets Enteric and Non-enteric Coated with Polymer Blends for Colon-specific Drug Release
    Journal of Neonatal Surgery | 2025-03-21 | Journal article | DOI: 10.52783/jns.v14.2412
  • Design and Development of Biosurfactant-Induced Nanosponges Using a QbD Approach. Part-I
    International Journal of Allied Medical Sciences and Clinical Research | 2021 | Journal article | Vol. 9(4), 748–761
  • Recent Approaches for Therapeutic Enzymes: Immobilization and Applications — A Review
    Pharma Science Monitor | 2013 | Review article | 3(4), 12–49
  • Immobilization and Characterization of Porcine Pancreas Lipase on “Gellasan”
    International Journal of Pharmaceutical Research and Technology (IJPRT) | 2013 | Journal article | 3(2), 20–25


  • Pharmacokinetic Studies of Doxorubicin-Loaded Chitosan-Crosslinked Gellan Gum Nanoparticles for Nose-to-Brain Delivery
    International Journal of Nanomedicine | 2023 | Journal article (Accepted / In press)
  • Lost in Translation: Methodological Pitfalls Hindering the Clinical Utility of Extracellular Vesicle- and Circulating miRNA Biomarkers in Diabetic Kidney Disease
    Nature Medicine | 2025 | Commentary/Review (Under communication)
  • AI-Enabled HPLC for Biosimilars
    Trends in Analytical Chemistry | 2025 | Review (Communicated)
  • mRNA Vaccines in the One-Health Era: Bridging Human, Veterinary, and Zoonotic Applications
    Archives of Microbiology | 2025 | Review (Communicated)
  • Mapping India’s Contribution to Global miRNA Research: A Bibliometric and Systematic Review
    (Under communication) | 2025 | Review
  • AI-Enhanced Isothermal Biosensors for Water-Borne Pathogen Detection in Low-Resource Settings
    Nature Water | 2025 | Perspective/Review (Communicated)
  • CRISPR-Dx for One Health India: A Perspective
    Journal of Applied Biology and Biotechnology | 2025 | Perspective (Communicated)
  • Polysaccharide-Based Nanoparticles: Emerging Advances in Lung Cancer Therapy
    Cancer and Metastasis Reviews | 2025 | Review (Under communication)
  • AI-Guided ADMET and Dose Design of Indian Ethnomedicinal Antidiabetic Phytochemicals: An In-Silico Pipeline with Docking, MD, and PBPK Simulation
    Natural Resources for Human Health | 2025 | Article (Under communication)
  • Computational Approaches to Study ecDNA in Cancer Genomics
    Extrachromosomal DNA in Cancer: Mechanisms, Biomarkers, and Therapeutic Implications (Taylor & Francis) | 2025 | Book chapter (Communicated) |
  • ecDNA in Oncogene Amplification and Tumor Progression
    Extrachromosomal DNA in Cancer: Mechanisms, Biomarkers, and Therapeutic Implications (Taylor & Francis) | 2025 | Book chapter (Communicated) |
  • A Focused Systematic Review and Meta-Analysis of Genetic Mutations, Survival Outcomes, Ethnic Variations, Androgen Receptor Status, and Secondary Cancer Risks in Male Breast Cancer: Insights from Breast Cancer Research and Treatment Journal
    PROSPERO ID: CRD42024600690 | Date created: 12 Oct 2024 | Last edited: 06 Aug 2025
  • The Role of TP53 Gene Variants in Breast Cancer Prognosis: A Systematic Review and Meta-Analysis
    PROSPERO ID: CRD42024605072 | Date created: 23 Oct 2024 | Last edited: 04 Nov 2024
  • Prognostic Impact of BRCA Mutations on Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
    PROSPERO ID: CRD42024604172 | Date created: 21 Oct 2024 | Last edited: 31 Oct 2024

References

  • Dr. Aatmaram Pawar, Principal, Poona College of Pharmacy, Pune, Maharashtra
  • Dr. S. S. Pisal, Director, Serum Institute of India, Pune, Maharashtra
  • Dr Praful Bharadia, Professor, L M College of Pharmacy, Ahmedabad, Gujarat
  • Dr. C. R. Kokare, Principal, Sinhagad Institute of Pharmacy, Pune, Maharashtra, 411041

Personal data processing

I hereby declare that all the above information is true to my knowledge and conscience.

Timeline

Prof

Hon. Shri Babanrao Pachpute Vichardhara Trust's Group of Institutions
04.2024 - Current

Marketing CEO

SAI Pharma
11.2015 - 12.2021

Asst. Prof

Vidyabharti Trust College of Pharmacy
09.2006 - 07.2015

High School Diploma - GATE - Conducted By Indian Institute of Technology

GATE
04.2001 -

M. Pharm. - Pharmaceutical Biotechnology

Bharti vidyapeeth's Poona College of Pharmacy

Startup Founder

Shakite Wellness
2025 - Current

Startup Founder

EdCredo
2025 - Current

Startup Founder

LYL India
2025 - Current

Ph.D. - Pharmaceutical Sciences

Hemchandracharya North Gujarat University

B. Pharm. -

ROFEL College of Pharmacy
Nikunj SolankiProfessor